Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorTianjin Medical University
About this trial
To evaluate the potential usefulness of 68Ga/18F-Pentixafor/Pentixather positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various CXCR4-related disease patients.
Eligibility criteria
Qualifiers
suspected or confirmed untreated Lymphoproliferative and other CXCR4-related diseases patients
18F-FDG PET/CT within two weeks
signed written consent.
Disqualifiers
pregnancy
breastfeeding
known allergy against Pentixafor
Trial design
Treatments tested in this trial
- CXCR4 PET/CT Imaging
Treatment groups
200 Participants
are divided into 1 treatment groupLocations
1Tianjin Medical University General Hospital300052, TianjinTianjin Municipality, China
Sponsors and collaborators
Tianjin Medical University
Lead sponsor
Tianjin Medical University General Hospital
Collaborator
Source ClinicalTrials.gov